{"name":"Guard Therapeutics AB","slug":"guard-therapeutics-ab","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNa3pKNWVVQWJKa01HNnNOTm5TVDBUWWNlV2dxNE1WYUhJb01CblEzZV8xWWtUb2VmajZrOGg0Zm40NGxqVmw5bm9RV28tV2cwQ05IelFxMGlyYTdzRXJRN1UwNmFzaGJNRVJubE9UQmRLTlBHR0FVZGRGRll5Sm9wcng1OGdvZFBxelhpTFZremVYX1hyQUtSUFIzOXk?oc=5","date":"2026-04-08","type":"pipeline","source":"openPR.com","summary":"Trends in Growth, Segment Analysis, and Competitive Strategies Influencing the Acute Kidney Injury Market - openPR.com","headline":"Trends in Growth, Segment Analysis, and Competitive Strategies Influencing the Acute Kidney Injury Market","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-12","type":"pipeline","source":"simplywall.st","summary":"3 European Growth Stocks With Up To 31% Insider Ownership - simplywall.st","headline":"3 European Growth Stocks With Up To 31% Insider Ownership","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-10","type":"pipeline","source":"simplywall.st","summary":"Breakeven Is Near for Guard Therapeutics International AB (publ) (STO:GUARD) - simplywall.st","headline":"Breakeven Is Near for Guard Therapeutics International AB (publ) (STO:GUARD)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQcFFZcFBRRUVJVFhaQXpEVVI0NGFkVzhKejdDLUJYdWR6TUJfVi1KdzdjRmpiUFBPNmx4NWpqUEFKb3dyREtsZ2NsLTJ4UHBnbGVCRVFURlVxWDZUa3VjNlpUVlpBOUtEMEFjUmduZ3dieWl6Q3otY2FGYm94Sk92UVhxdUM4RkFNWXdLNkJwZw?oc=5","date":"2024-02-08","type":"pipeline","source":"Frontiers","summary":"Editorial: Biomarkers of Oxidative Stress - Frontiers","headline":"Editorial: Biomarkers of Oxidative Stress","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxObXJ2TWpVTmVGVGoxZVZHZFUwOGhzR2dzclp2dktEczRnTndFLWcyYkxocEJnSG1hWFA0RmYtSWtlaVBsOVJEYVNnNnp3WGdWUUZ0alBKSEFhVHZVSGZOcjJPMUNNakFKSDliVlNDS1pBSjdHM01xdzR6ZTdOVE1ocHVUQVBGZktxeGNkdVNqYmFleDN5VWQ0bEpqSUNJZHhaQl9EaWxNeUUwbXloXzY1eTFUQmZMUm9PTUdMR210Y2tUQ19CTTZGZWI3d01jdFJkTjU0Ynk0TQ?oc=5","date":"2024-02-01","type":"pipeline","source":"BioWorld News","summary":"Guard Therapeutics outlines progress within preclinical peptide platform targeting chronic diseases - BioWorld News","headline":"Guard Therapeutics outlines progress within preclinical peptide platform targeting chronic diseases","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}